The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, meet the researchers improving kidney surgery certainty, discover how we solved a molecular puzzle and learn how to support our work.
A new function has been found for one of the first cancer genes ever discovered.
A blood test that measures the number of cells shed from prostate tumours into the bloodstream can act as an early warning sign that treatment is not working.
Drugs that target BRCA gene mutations could treat a wider population of patients than previously thought, according to research carried out at the ICR and across Europe
Pioneering phase I studies of new cancer drugs
Personalising treatments for patients on clinical trials
Developing new drugs for hard-to-treat childhood cancers
How mouse 'avatars' could help tailor cancer treatments in head and neck cancers
Genome analysis at our Tumour Profiling Unit – discovering cancer’s weaknesses
Our PhD students conduct world-class research projects, while our MSc in Clinical Oncology teaches about the latest in clinical practice.
Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
The ICR’s research aims to learn more about cancer genetics and tumour biology – and use that information in discovering new treatments.
Your support can help us fight an often overlooked form of cancer, one that claims an increasingly large number of lives every year.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.
High hopes for hypofractionation in search for cheaper, better radiotherapy
Taking some of the uncertainties out of cancer surgery
Seven things you learn while surrounded by data
We worked with scientists from @uclnews to find a new role for an 'old' gene http://t.co/CXSveUs3bC